The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.

The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.

The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.

The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.

George Rosenkranz was part of a team in Mexico City that first synthesized norethindrone in 1951.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

A drive for revenue is damaging basic science.